Mundipharma appoints Patrice Grand

Mundipharma appoints Patrice Grand as European Director of Corporate Communications

Mundipharma appoints Patrice Grand to the position of European Director of Corporate Communications, reporting to Alberto Martinez, President and Chief Executive Officer in Europe. Patrice...
Katie Bright has been promoted to Director at Makara Health.

Makara Health expands leadership team

Makara Health has promoted Katie Bright to Director, responsible for the agency’s engagement offering. Bright will work alongside PR and communications specialist Helen Laurence, recently...
Dr Allan Jordan and Ms Louisa Jordison have joined Sygnature Discovery.

Sygnature Discovery makes key appointments

Sygnature Discovery has made two key appointments, Dr Allan Jordan and Ms Louisa Jordison. Ms Jordison joins the independent integrated drug discovery and pre-clinical services...
A guide to going paperless in healthcare

Sanofi appoints Chief Digital Officer

Sanofi appoints Chief Digital Officer, Ameet Nathwani, MD, will also continue to serve as Executive Vice-President, Chief Medical Officer. As Chief Digital Officer, Dr....
Kieran Chouhan of Recipharm

Recipharm appoints new Director of Business Management

Recipharm, the contract development and manufacturing organisation (CDMO), has appointed a new Director of Business Management for the USA and Canada to accelerate growth...
Exscientia enters drug discovery partnership with Celgene

The Wasdell Group appoint Vincent Dunne to CEO

The Wasdell Group an outsourcing partner for the life science industry, has announced the appointment of its new CEO, Vincent Dunne Vincent will be...
Star Europe reports positive client and candidate feedback.

Star Europe’s Amsterdam office off to positive start

Star Europe has reported good feedback in the Netherlands since opening its Amsterdam office in November. Supported by established resources and infrastructure, the team at...
Immunocore appoint Bahija Jallal as Chief Executive Officer

Immunocore appoints Bahija Jallal as Chief Executive Officer

Immunocore, a T Cell Receptor biotechnology company, has appointed Bahija Jallal as Chief Executive Officer and Director of the Board. With more than 25 years...
Thinking outside of the box: sales insight using AI

Improve your sales insight using AI

Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...

OBN appoints new Chairman and Non-Executive Director

OBN, the membership organisation supporting the UK’s innovative life sciences companies, announces the following changes to its Board. Bill Fleming has been appointed the new...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...